trans-4-(aminomethyl)cyclohexane carboxylic acid (t-AMCHA), an anti- fibrinolytic agent, accelerates barrier recovery and prevents the epidermal hyperplasia induced by epidermal injury in hairless mice and humans

Journal of Investigative Dermatology

Volumn 109, Issue 1, 1997, Pages 84-90

  Denda, Mitsuhiro ^a   Kitamura, Kenji ^a   Elias, Peter M ^b,d   Feingold, Kenneth R ^b,c,d  

^a SHISEIDO RESEARCH CENTER   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Metabolism and Endocrine Sections   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Proteases; Stratum corneum; Transepidermal water loss

Indexed keywords

ANTIFIBRINOLYTIC AGENT; PLASMIN; SERINE PROTEINASE INHIBITOR; TRANEXAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; EPIDERMIS HYPERPLASIA; HUMAN; HUMAN EXPERIMENT; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SKIN DEFECT; SKIN PERMEABILITY; STRATUM CORNEUM; TOPICAL DRUG ADMINISTRATION;

EID: 0030847170     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12276640     Document Type: Article

References (41)

1. Baird J, Lazarus GS, Belin D, Vassalli JD, Busso N, Gubler P, Jensen PJ: mRNA for tissue type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. J Invest Dermatol 95:548-552, 1990
2. Beynon RJ, Salvesen G: Commercially available protease inhibitors. In: Beynon RJ, Bond JS (eds.). Proteolytic Enzymes. IRL Press, Oxford, UK, 1989
3. Denda M, Wood, LC, Emami S, Calhoun C, Brown BE, Elias PM, Feingold KR: Epidermal hyperplasia associated with repeated barrier disruption by acetone treatment or tape stripping cannot be attributed to increased water loss. Arch Dermatol Res 288:230-238, 1996
4. Elias PM, Holleran WM, Menon GK, Ghadially R, Williams ML, Feingold KR: Normal mechanisms and pathophysiology of epidermal permeability barrier homeostasis. Curr Opin Dermatol 231-237, 1993
5. Feingold KR, Man MQ, Menon GK, Cho SS, Brown BE, Elias PM: Cholesterol synthesis is required for cutaneous barrier function in mice. J Clin Invest 86:1738-1745, 1990
6. Galis ZS Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503, 1994
7. Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM: The aged epidermal permeability barrier: structural, functional and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest 95:2281-2290, 1995
8. Grice KA: Transepidermal water loss in pathologic skin. In: Jarrett A (ed.) The Physiology and Pathophysiology of the Skin Academic Press, London, 1980, pp 2147-2155
9. Grondahl-Hansen J, Lund LR, Ralfkiaer E, Otterangen V, Dano K: Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. J Invest Dermatol 90:790-795, 1988
10. Grubauer G, Elias PM, Feingold KR: Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res 30:323-334, 1989
11. Halkier-Sorensen L, Thastrup-Pedersen K: Skin physiological changes in employees in the fish processing industry immediately following work: a field study. Contact Dermatitis 25:19-24, 1991
12. Hashimoto K, Wun TC, Baird J: Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG induced acantholysis by a purified plasminogen activator inhibitor. J Invest Dermatol 92:310-314, 1989
13. Hausson L, Storomquist M, Backman A, Wallbundt P, Carlstein A, Egelrud T: Cloning expression and characterization of stratum corneum chymotryptic enzyme: a skin-specific human serine proteinase. J Biol Chem 269:19420-19426, 1994
14. Holleran WM, Man MQ, Gao WN, Menon GK, Elias PM, Feingold KR: Sphingolipids are required for mammalian barrier function: inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest 88:1338-1345, 1991
15. Holleran WM, Takagi Y, Menon GK, Legler G, Feingold KR, Elias PM: Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest 91:1656-1664, 1993
16. Hunziker T, Vassalli JD: Plasmin induces acantholysis in skin organ cultures. Arch Dermatol Res 279:341-346, 1987
17. Isseroff RR, Chun KT, Rosenberg RM: Triiodothyronine alters the cornification of cultured human keratinocytes. Br J Dermatol 120:503-510, 1989
18. Jensen PJ, Baird J, Morioka S, Lessin S, Lazarus GS: Epidermal plasminogen activator in abnormal cutaneous lesions. J Invest Dermatol 90:777-782, 1988
19. Jensen PJ, Baird J, Belin D, Vassalli JD, Busso N, Gubler P, Lazarus GS: Tissue plasminogen activator in psoriasis. J Invest Dermatol 95:13S-14S, 1990
20. Kitamura K, Yamada K, Ito A, Fukuda M: Research on the mechanism by which dry skin occurs and the development of an effective compound for its treatment. J Soc Cosmet Chem 29:133-145, 1995
21. Kramer MD, Schaefer B, Reinartz J: Plasminogen activation by human keratinocytes: Molecular pathways and cell-biological consequences. Biol Chem Hoppe-Seylar 3:131-141, 1995
22. Lyons-Giordano B, Lazarus GS: Skin abnormalities in mice transgenic for plasminogen activator inhibitor 1: Implications for the regulation of desquamation and follicular neogenesis by plasminogen activator enzymes. Dev Biol 170:289-298, 1995
23. Man MQ, Elias PM, Feingold KR: Fatty acids are required for epidermal barrier function. J Clin Invest 92:791-798, 1993a
24. Man MQ, Feingold KR, Elias PM: Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol 129:728-738, 1993b
25. Man MQ, Brown BE, Wu-Pong S, Feingold KR, Elias PM: Exogenous inert vs. physiological lipids: divergent mechanisms for correction of permeability barrier function. Arch Dermatol 131:809-816, 1995a
26. Man MQ, Feingold KR, Jain M, Elias PM: Extracellular processing of phospholipids is required for permeability barrier homeostasis. J Lipid Res 36:1925-1935, 1995b
27. Man MQ, Feingold KR, Thornfeldt CR, Elias PM: Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol 106:1096-1101, 1996
28. Marks R, Hill S, Barton SP: The effects of an abrasive agent on normal skin and photoaged skin in comparison with topical tretinoin. Br J Dermatol 123:457-466, 1990
29. Menon GK, Feingold KR, Moser AH, Brown BE, Elias PM: De novo sterologenesis in the skin: Fate and function of newly synthesized lipids. J Lipids Res 26:418-427, 1985
30. Pinnagoda J, Tupker RA, Coenraad PJ, Natar JP: Prediction of susceptibility to an irritant response by transepidermal water loss. Contact Dermatitis 20:341-346, 1989
31. Proksch E, Holleran WM, Menon GR, Elias PM, Feingold KR: Barrier function regulates epidermal lipid and DNA synthesis. Br J Dermatol 128:473-482, 1993
32. Reinartz J, Batrla R, Boukamp P, Fusenig N, Kramer MD: Binding and activation of plasminogen at the surface of human keratinocytes. Exp Cell Res 208:197-208, 1993
33. Romer J, Bugge TH, Pyke C, Lund LR, Flick BJ, Degan JL, Dano K: Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 2:287-292, 1996
34. Romer J, Lund LR, Eriksen J, Raltkiaer E, Zeheb R, Gelehrter TD, Dano K, Kristiansen P: Differential expression of urokinase-type plasminogen activator and its type 1 inhibitor during healing of mouse skin wounds. J Invest Dermatol 97:803-811, 1991
35. Romer J, Lund LR, Eriksen J, Pyke C, Kristensen P, Dano K: The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds. J Invest Dermatol 102: 519-522, 1994
36. Scott IR, Harding CR: Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by water activity of the environment. Dev Biol 115:84-92, 1986
37. Spiers EM, Lazarus GS, Lyons-Giordano B: Expression of plasminogen activator enzymes in psoriatic epidermis. J Invest Dermatol 102:333-338, 1994
38. Suzuki Y, Nomura J, Koyama J, Horii I: The role of protease in stratum corneum: involvement in stratum corneum desquamation. Arch Dermatol Res 286:249-253, 1994
39. Taljebini M, Warren R, Man MQ, Lane E, Elias PM, Feingold KR: Cutaneous permeability barrier repair following various types of insults: kinetics and effects of occlusion. Skin Pharmacol 9:111-119, 1996
40. Vassalli JD, Sappino AP, Belin D: The plasminogen activator/plasmin system. J Clin Invest 88:1067-1072, 1991
41. Wiedow O, Wiese F, Streit V, Kalm C, Christophers E: Lesional elastase activity in psoriasis, contact dermatitis and atopic dermatitis. J Invest Dermatol 99:306-309, 1992